Sleep apnea devices have become conveniently accessible due to the advancement in technology as a number of the key market players are developing and launching new devices to expand their market. Moreover, rising healthcare expenditure in developed as well as a developing countries has fueled the growth of the sleep apnea devices market. The sleep apnea devices market is growing due to the increased prevalence of the elder population with sleep disorders and the rise in technological advancement.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-sleep-apnea-devices-market
Global Sleep Apnea Devices Market was valued at USD 4,123.98 million in 2021 and is expected to reach USD 7,716.59 million by 2029, registering a CAGR of 7.60% during the forecast period of 2022-2029. The demand for the sleep apnea devices market has increased in both developed and developing countries, and the reason behind this is increasing strategic initiatives by key players. Lack of accessibility is expected to hinder the global sleep apnea devices market growth.
The rise in the geriatric and obese population is expected to drive the market's growth rate
Obesity is a health disorder that increases the likelihood of health complications. In recent decades, in the United States and Canada, obesity is a serious health problem leading to coronary heart disease, which results in death. Obesity incidents in North America, particularly the United States, Mexico, and Canada, remain the world's highest. Thus, the rise in the obese population, which is further expected to increase in the coming years, is a major driver for the market.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Diseases Type (Obstructive Sleep Apnea Syndrome, Central Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome), Type (Devices, Therapy), Patient Demographics (Pediatric, Adult, Geriatric), End User (Hospital/ Clinics, Diagnostic Centers, Ambulatory Care Centers, Specialty Care Centers, Home Healthcare), Distribution Channel (Direct Tender, Retail Sales)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
Market Players Covered
|
Koninklijke Philips N.V. (Netherlands), Itamar Medical Ltd. (Israel), Natus Medical Incorporated (US), CONTEC MEDICAL SYSTEMS CO., LTD (China), ResMed (US), BMC Medical Co., Ltd. (China), SomnoMed (Australia), Fisher & Paykel Healthcare Limited (New Zealand), Medicom MTD Ltd (Russia), Somnowell (UK), Compumedics Limited (Australia), SIBELMED (Barcelona), APEX MEDICAL CORP. (Taiwan), Inspire Medical Systems, Inc. (US), NIHON KOHDEN CORPORATION (Japan), DeVilbiss Healthcare LLC (US), nox medical (Iceland), Advanced Brain Monitoring, Inc. (US), Cleveland Medical Devices Inc. (US), Braebon Medical Corporation (Canada), Löwenstein Medical Technology GmbH + Co. KG. (Germany), and Nyxoah SA (Belgium) among others
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global sleep apnea devices market is categorized into five notable segments which are based on the diseases type, type, patient demographics, end user and distribution channel.
- On the basis of diseases type, the global sleep apnea devices market is segmented into obstructive sleep apnea syndrome, central sleep apnea syndrome and complex sleep apnea syndrome. In 2021, obstructive sleep apnea syndrome segment is expected to dominate the market with 64.60% market share due to rising prevalence of chronic obese population and high body mass index individuals.
- On the basis of type, the global sleep apnea devices market is segmented into device and therapy. In 2021, device segment is expected to dominate the market with 85.83% market share due to surge in technological advancements in novel therapeutics options for convenient applications.
- On the basis of patient demographics, global sleep apnea devices market is segmented into pediatric, adult and geriatric. In 2021, adult segment is expected to dominate the market with 58.78% market share due to rising prevalence of elderly population with accompanied chronic diseases as diabetes and obesity.
- On the basis of end user, global sleep apnea devices market is segmented into hospital/clinics, diagnostic centers, ambulatory care centers, specialty care center and home healthcare. In 2021, home healthcare segment is expected to dominate the market with 36.91% market share as it provides patients with the best and accessible healthcare services.
The home healthcare will dominate the end user segment of the global sleep apnea devices market
In 2022, the home healthcare segment is expected to flourish its dominance by acquiring more than 37% of the market share. This is because of the growth and expansion of the healthcare industry and growing demand for critical care by geriatric population base.
- On the basis of distribution channel, global sleep apnea devices market is segmented into direct tender and retail sales. In 2021, retail sales is expected to dominate the market with 71.19% market share as it provides quality and accessible sleep apnea devices to various hospitals, diagnostic centers, ambulatory and specialty care centers.
The retail sales will dominate the distribution channel segment of the global sleep apnea devices market
- In 2022, the retail sales segment is expected to flourish its dominance by acquiring more than 71% of the market share. This is because of the growing number of retailers in the market.
Major Players
Data Bridge Market Research recognizes the following companies as the major market players in market are Koninklijke Philips N.V. (Netherlands), Itamar Medical Ltd. (Israel), Natus Medical Incorporated (US), CONTEC MEDICAL SYSTEMS CO., LTD (China), ResMed (US), BMC Medical Co., Ltd. (China), SomnoMed (Australia), Fisher & Paykel Healthcare Limited (New Zealand), Medicom MTD Ltd (Russia), Somnowell (UK), Compumedics Limited (Australia), SIBELMED (Barcelona), APEX MEDICAL CORP. (Taiwan), Inspire Medical Systems, Inc. (US), NIHON KOHDEN CORPORATION (Japan), DeVilbiss Healthcare LLC (US), nox medical (Iceland), Advanced Brain Monitoring, Inc. (US), Cleveland Medical Devices Inc. (US), Braebon Medical Corporation (Canada), Löwenstein Medical Technology GmbH + Co. KG. (Germany), and Nyxoah SA (Belgium).
Market Development
- In April 2020, Itamar Medical Ltd. signed a collaboration agreement with BetterNight, a leading comprehensive sleep solution provider. This collaboration was aimed at offering sleep apnea patients home care virtual-care sleep solutions for diagnosis and treatment. This is expected to assist the company in improving revenue for market
- In October 2019, Cahaba Media Group, Inc. announced that the latest advancements such as 3D Scanning are included in developing patient-centric CPAP masks. Thereby these masks provide a personalized fitting experience with data-driven guidance for easy use
- Em abril de 2021, a Natus Medical Incorporated anunciou que o seu CEO e presidente seriam apresentados na 20ª Conferência Virtual Anual de Saúde Needham. Esta conferência oferecerá discussões individuais com investidores de várias instituições, fortalecendo assim a relação com os investidores e impulsionando o crescimento para o futuro.
Análise Regional
Geograficamente, os países abrangidos pelo relatório de mercado são os EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Holanda, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, Resto da Europa na Europa, China, Japão, Índia, Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC), Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egito, Israel, Resto do Médio Oriente e África (MEA) como parte do Médio Oriente e África (MEA), Brasil, Argentina e Resto da América do Sul como parte da América do Sul.
De acordo com a análise de pesquisa de mercado da Data Bridge:
A América do Norte é a região dominante no mercado de dispositivos para a apneia do sono durante o período previsto de 2022 a 2029
A América do Norte domina o mercado dos dispositivos para a apneia do sono. Isto deve-se à prevalência de infraestruturas de saúde avançadas na região, equipadas o suficiente para lidar com o aumento de casos de doenças respiratórias na região. O aumento da população que sofre de diabetes tipo 2 é uma causa provável da apneia obstrutiva do sono, o que, por sua vez, está a fomentar a procura de dispositivos para a apneia do sono.
Estima-se que a região da Ásia-Pacífico seja a de crescimento mais rápido no mercado de dispositivos para a apneia do sono no período previsto de 2022 a 2029.
A Ásia-Pacífico (APAC) tornar-se-á a região territorial com a maior taxa de crescimento durante o período previsto de 2022 a 2029. A insuficiência cardíaca congestiva e a hipertensão arterial aumentam o risco de desenvolver apneia obstrutiva do sono. Assim sendo, o aumento da incidência dos mesmos entre a população desta região, aliado à crescente prevalência de doenças relacionadas com o estilo de vida, aumentará a procura de dispositivos para a apneia do sono.
Análise de Impacto da COVID-19
A COVID-19 teve um impacto negativo no mercado de dispositivos para a apneia do sono. Os desafios operacionais e logísticos do mercado, resultado dos bloqueios nacionais, reduziram a procura de dispositivos para a apneia do sono. Como resultado do impacto negativo do vírus nos doentes com apneia do sono, verificou-se um aumento da procura e da produção de dispositivos para a apneia do sono, como máscaras, ventoinhas de sono e dispositivos PAP. A telemedicina e as teleconsultas tiveram um rápido crescimento durante a pandemia e prevê-se que continuem a crescer no cenário pós-pandemia, apoiando o crescimento do mercado de dispositivos para a apneia do sono.
Para obter informações mais detalhadas sobre o relatório de mercado de dispositivos para apneia do sono , clique aqui – https://www.databridgemarketresearch.com/reports/global-sleep-apnea-devices-market
